LJAC
L.J. Altfest & Co Portfolio holdings
AUM
$848M
This Quarter Return
+3.39%
1 Year Return
+21.11%
3 Year Return
+48.61%
5 Year Return
+74.16%
10 Year Return
+153.72%
AUM
$93.9M
AUM Growth
+$93.9M
(-8.8%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-13.6%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
109
New
3
Increased
24
Reduced
33
Closed
43
Top Buys
| 1 |
Apple
AAPL
|
$1.92M |
| 2 |
Medtronic
MDT
|
$685K |
| 3 |
Chevron
CVX
|
$131K |
| 4 |
ECF
Ellsworth Growth & Income Fund
ECF
|
$95K |
| 5 |
Bristol-Myers Squibb
BMY
|
$83.4K |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$953K |
| 2 |
3M
MMM
|
$925K |
| 3 |
Yum! Brands
YUM
|
$726K |
| 4 |
Walt Disney
DIS
|
$681K |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$605K |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Consumer Staples | 18.61% |
| 3 | Technology | 17.02% |
| 4 | Energy | 11.46% |
| 5 | Real Estate | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exxon Mobil
XOM
$487B
| $5.47M | 5.39% | 53,309 +506 | +1% | +$51.9K |
|
2
PepsiCo
PEP
$204B
| $4.87M | 4.8% | 54,235 -1,158 | -2% | -$104K |
|
|
OLP
3
One Liberty Properties
OLP
$516M
| $4.32M | 4.25% | 199,519 | – | – |
|
4
IBM
IBM
$227B
| $3.92M | 3.86% | 20,858 -33 | -0.2% | -$6.21K |
|
5
Johnson & Johnson
JNJ
$427B
| $3.31M | 3.26% | 31,121 +67 | +0.2% | +$7.13K |
|
6
Microsoft
MSFT
$3.77T
| $2.93M | 2.88% | 69,683 -123 | -0.2% | -$5.17K |
|
7
Verizon
VZ
$186B
| $2.76M | 2.72% | 55,540 +1,447 | +3% | +$72K |
|
|
8
Bristol-Myers Squibb
BMY
$96B
| $2.55M | 2.51% | 53,029 +1,738 | +3% | +$83.4K |
|
9
GE Aerospace
GE
$292B
| $2.47M | 2.43% | 92,405 +1,577 | +2% | +$42.2K |
|
10
Cisco
CSCO
$274B
| $2.31M | 2.27% | 91,373 +926 | +1% | +$23.4K |
|
|
11
Apple
AAPL
$3.45T
| $2.2M | 2.16% | 22,882 +20,002 | +695% | +$1.92M |
|
|
12
Chevron
CVX
$324B
| $1.96M | 1.93% | 15,026 +1,002 | +7% | +$131K |
|
|
DTV
13
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.92M | 1.89% | 22,347 -98 | -0.4% | -$8.42K |
|
14
Walmart
WMT
$774B
| $1.73M | 1.7% | 22,749 -359 | -2% | -$27.3K |
|
15
Amgen
AMGN
$155B
| $1.73M | 1.7% | 14,368 -15 | -0.1% | -$1.8K |
|
16
AstraZeneca
AZN
$248B
| $1.7M | 1.68% | 22,448 -286 | -1% | -$21.7K |
|
17
Oracle
ORCL
$635B
| $1.7M | 1.67% | 41,481 +877 | +2% | +$35.9K |
|
18
Abbott
ABT
$231B
| $1.66M | 1.63% | 39,970 -263 | -0.7% | -$10.9K |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $1.65M | 1.62% | 30,351 -107 | -0.4% | -$5.8K |
|
20
Kimberly-Clark
KMB
$42.8B
| $1.64M | 1.62% | 14,658 -108 | -0.7% | -$12.1K |
|
21
Archer Daniels Midland
ADM
$30.1B
| $1.6M | 1.57% | 34,346 -323 | -0.9% | -$15K |
|
22
Norfolk Southern
NSC
$62.8B
| $1.58M | 1.56% | 15,349 -65 | -0.4% | -$6.71K |
|
23
GSK
GSK
$79.9B
| $1.55M | 1.53% | 28,678 -229 | -0.8% | -$12.4K |
|
24
Procter & Gamble
PG
$368B
| $1.51M | 1.48% | 18,771 -344 | -2% | -$27.6K |
|
25
Travelers Companies
TRV
$61.1B
| $1.5M | 1.48% | 15,880 -33 | -0.2% | -$3.12K |
|